TSPAN33 Is a Novel Marker of Activated and Malignant B Cells

Clinical Immunology - United States
doi 10.1016/j.clim.2013.08.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

HLA-F Is a Surface Marker on Activated Lymphocytes

European Journal of Immunology
AllergyImmunology
2010English

Differentiation of Malignant B-Lymphoma Cells From Normal and Activated T-Cell Populations by Their Intrinsic Autofluorescence

Cancer Research
Cancer ResearchOncology
2009English

The Long Non-Coding RNA HOTAIR Is Transcriptionally Activated by HOXA9 and Is an Independent Prognostic Marker in Patients With Malignant Glioma

Oncotarget
Oncology
2018English

A Proteolytically Truncated Form of Free CD18, the Common Chain of Leukocyte Integrins, as a Novel Marker of Activated Myeloid Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Utility of D2-40, a Novel Mesothelial Marker, in the Diagnosis of Malignant Mesothelioma

Modern Pathology
Forensic MedicinePathology
2004English

Sam68 Is a Novel Marker for Aggressive Neuroblastoma [Corrigendum]

OncoTargets and Therapy
OncologyPharmacology
2014English

NKG2A Is a Marker for Acquisition of Regulatory Function by Human CD8+T Cells Activated With Anti-Cd3 Antibody

European Journal of Immunology
AllergyImmunology
2011English

Glycoprotein NMB: A Novel Alzheimer’s Disease Associated Marker Expressed in a Subset of Activated Microglia

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

Melanoma Cell Adhesion Molecule Is a Novel Marker for Human Fetal Myogenic Cells and Affects Myoblast Fusion

Journal of Cell Science
Cell Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy